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Abstract. The fibronectin receptor, ,5fl l ,  has been 
shown to be required for fibronectin matrix assembly 
and plays an important role in cell migration on 
fibronectin. However, it is not clear whether other 
fibronectin binding integrins can take the place of 
et5B1 during matrix assembly and cell migration. To 
test this, we expressed the human ~v subunit in the 
CHO cell line CHO-B2 that lacks the o~5 subunit. We 
found that the human oev combined with CHO cell/31 
to form the integrin otvB1. Cells that expressed otv/31 
attached to and spread well on fibronectin-coated 
dishes, but did so less well on vitronectin-coated 
dishes. This, along with other data, indicated that 
c~v/31 functions as a fibronectin receptor in CHO-B2 
cells. The otv/31-expressing cells failed to produce a 
fibronectin matrix or to migrate on fibronectin, al- 
though the same cells transfected with or5 do produce 
a matrix and migrate on fibronectin. The affinity of 
the avfll-expressing cells for fibronectin was fourfold 
lower than that of the ,5fll-expressing cells. In addi- 
tion, otv/31 was distributed diffusely throughout the 
cell surface, whereas oe5/31 was localized to focal 
adhesions when cells were seeded onto fibronectin- 
coated surfaces. Thus, of the two fibronectin recep- 
tors, av/31 and o~5/31, only ot5/31 supports fibronectin 
matrix assembly and promotes cell migration on 
fibronectin in the CHO-B2 cells. Possible reasons for 
this difference in the activities of av/$1 and o~5/31 in- 
elude the lower affinity of ~,v/~ 1 for fibronectin and the 
failure of this integrin to localize in adhesion plaques 
on a fibronectin substrate. These results show that two 
integrins with similar ligand specificities and cell at- 
tachment functions may be quite different in their abil- 
ity to support fibronectin matrix assembly and cell 
motility on fibronectin. 
T 
HE pericellular fibronectin matrix plays an important 
role in cell adhesion, migration, and growth control 
(Hynes, 1990; Ruoslahti and Giancotti, 1990). The 
main receptor for fibronectin in many cells is the ot5/31 inte- 
grin (Pytela et al., 1985a; Ruoslahti, 1991). This integrin not 
only attaches cells to the fibronectin matrix, hut also regu- 
lates the formation of this matrix. That ot5/31 participates in 
matrix formation is clear from a number of observations; an- 
tibodies against a5/31 inhibit matrix formation (Akiyama et 
al., 1989; Fogerty and Mosher, 1990), lowering the expres- 
sion of ot5/~l can eliminate matrix deposition, whereas rein- 
troduction of the integrin restores matrix deposition (Wu, 
C., J. S. Bauer, R. L. Juliano, and J. A. McDonald, personal 
communication). Moreover, the amount of matrix deposited 
is proportional to the amount of ot5~1 on the cells; overex- 
pression of ot5/~ 1 from transfected eDNA increases the depo- 
sition of fibronectin matrix (Giancotti and Ruoslahti, 1990). 
Malignant transformation often reduces the expression of the 
ot5/~l integrin and this is accompanied by a loss of fibronec- 
tin matrix around the transformed cells (Plantefaber and 
Hynes, 1989). The matrix loss is thought to contribute to the 
migratory and invasive properties of such cells. In fact, over- 
expression of the c~5/31 integrin in CHO cells drastically re- 
stricts the ability of these cells to migrate and makes them 
non-tumorigenic (Giancotti and Ruoslahti, 1990), whereas 
elimination of the integrin has the opposite effect (Schreiner 
et al., 1991). 
To better understand the role of fibronectin receptors in 
fibronectin matrix assembly and cell motility, we tested 
whether a fibronectin receptor other than ct5/31 could func- 
tion in these processes. In addition to ot5/31, other integrins 
have also been found to bind to fibronectin including: tx3/31, 
t~4t31, avfll, ctv/33, and otv/36 (Ruoslahti, 1991; Busk et al., 
1992). Of these integrins, otv/31 was of particular interest be- 
cause, like ot5/31, it binds to the Arg-Gly-Asp (RGD) site in 
fibronectin (Vogel et al., 1990). We engineered an ,v/31- 
expressing cell line by using a CHO cell line that was 
selected to be essentially devoid of the ct5 subunit and that 
has lost its ability to attach to fibronectin (Schreiner et al., 
1989), to migrate on fibronectin (Bauer et al., 1992), or to 
form a fibronectin matrix (Wu, C., J. S. Bauer, R. L. Juliano, 
and J. A. McDonald, personal communication). These bio- 
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logical activities are restored, however, by transfecting the 
cells with the human ct5 subunit (Bauer et al., 1992; Wu, C., 
J. S. Bauer, R. L. Juliano, and J. A. McDonald, personal 
communication). In this report we find that expressing the 
avfll integrin by transfection of the human otv into the ot5- 
deficient cells enabled the cells to attach to fibronectin, how- 
ever, in contrast to a5fll, avB1 supported neither fibronectin 
matrix assembly nor cell migration on fibronectin. 
Materials and Methods 
Materials 
c~-MEM and Geneticin (G418) were purchased from GIBCO BRL 
(Gaithersburg, MD), methionine-deficient MEM from ICN Biomedicals 
(Costa Mesa, CA), FBS from Tissue Culture Biologicais (Tulare, CA), and 
Glutamine Pen-Strep from Irvine Scientifc (Santa Ana, CA). Iodo-Gen was 
obtained from Pierce Chemical Co. (Rockford, IL). Acrylamide was pur- 
chased from Bethesda Research Laboratories (Gaithersburg, MD). Micro- 
titration multi-well plates were obtained from Flow Laboratories (McLean, 
VA). Human plasma fibronectin was from the Finnish Red Cross and 
vitroneetin from Telios Pharmaceuticals (La Jolla, CA). The ll0-kD 
fibronectin fragment containing the cell binding domain was made as previ- 
ously described (Pierschbacher et al., 1981). Peptides GRGDSP and 
GRGESP were synthesized at the Protein Chemistry Laboratory of the La 
Jolla Cancer Research Foundation (La Joila, CA). All other reagents were 
acquired from Sigma Immunochemicals (St. Louis, MO). 
An o~5fll-deflcient CHO cell line (B2), which expresses ",,2% of the wild 
type level of otSfll (Schreiner et al., 1989) was used for transfectiun experi- 
ments. CHO-B2 ceils transfected with the a5 integrin subunit (1132/o27 
clone) have previously been described (]Bauer et al., 1992). The B2/ot27 
clone expressed 3.4 times more ct5fll than the wild type CHO cell line. The 
CHO-B2 cells were grown in ct-MEM with 10% FBS and 2.5/~g/ml Gluta- 
mine Pen-Strep. The B2/a27 cells were grown in the same medium contain- 
ing 400/~g/ml G-418. 
Transfection of av cDNA 
A 4.2-kb human integrin ~ eDNA (Suzuki et al., 1987), which includes 
the entire otv coding sequence, was cloned into the mammalian expression 
vector peDNA1/neo (Invitrogen, La Joila, CA; Felding-Habermann et al., 
1992). The plasmid DNA was introduced into B2 cells by calcium phos- 
phate transfeetion (Cben and Okayama, 1988). Cells were split 2 d after 
transfection and grown in medium containing 400 #g/mi G418 for 10 more 
days. The G418-resistant colonies were cloned and expanded, and av- 
expressing clones were identified by immunoblotting of cell extracts (Gian- 
cotti and Ruoslahti, 1990) with anti-human c~v mAb 137 (Freed et al., 
1989). The parental vector pcDNAl/neo was also transfected into B2 cells 
to generate control clones. 
Integrin Analysis 
Integrin expression in the B2 cells and in the transfectants was evaluated 
by surface iodination of cells and immunoprecipitation with anti-integrin 
antibodies (Pytela et ai., 1985a,b; Vogel et al., 1993). Cells were lysed in 
RIPA buffer (1% NP-40, 0.5% DOC, 0.1% SDS, 150 mM NaCl, 50 mM 
Tris, pH 8.0) for 30 rain on ice. After a 20-rain centrifugation at 16,000 g, 
supernatants were used for immunoprecipitation. The antibodies used were 
mAb P1D6 (anti-human ~5; Wayner et al., 1988), mAb 147 (anti-human 
,v ;  Freed et ai., 1989), an anti-a5 cytoplasmic domain polyclonal antibody 
(Giancotti and Ruoslahti, 1990), an anti-fl3 cytoplasmic domain polyclonat 
antibody, and an anti-av cytoplasmic domain polyclonal antibody (Vogel et 
al., 1993). mAb DH2 (anti-ganglioside GM3; Kojima and Hakomori, 1991) 
and an unrelated polyclunal antibody were used as controls. 
The level of expression of integrins was measured by FACS analysis. 
B2/cl, B2/ot27, and B2/v7 ceils were detached with 5 mM EDTA in PBS. 
After three washes with cold PBS, ceils were stained with anti-av mAb 147 
or anti-a5 mAb P1D6 followed by a FITC-conjugated goat anti-mouse IgG 
(Sigma Immunochemicals) staining. Cells were fixed with ethanol and ana- 
lyzed with a FACStar machine (Bectun Dickinson Immunocytometry Sys- 
tems, Mountain View, CA). 
Cell Attachment Assay 
Cell attachment to coated fibronectin and vitronectin was assayed in micro- 
titer plates as previously described (Pytela et ai., 1985b; Giancotti and 
Ruoslahti, 1990). Quantitation of cell attachment was achieved by staining 
cells with 0.5% crystal violet in 20% methanol, washing cells, and then 
eluting the dye with 0.1 M sodium citrate, pH 4.2, and measuring the absor- 
bance at 600 am. 
Integrin AJffnity Measurement 
Iodination of the cell-binding 110-kD fibronectin fragment was done as de- 
scribed elsewhere (Morla and Ruoslahti, 1992). The specific activity of the 
radioiodinated ll0-kD fragment was typically 1.6 × 10 I° t~Ci/mmol. The 
binding of the 125I-l10-kD fragment to cells in suspension was performed 
essentially as previously described (Akiyama and Yamada, 1985). Briefly, 
cells were detached with 10 mM EDTA in PBS, washed three times with 
~-MEM and once with binding buffer (1% BSA, 25 mld Hepes, pH 7.3, 
in a-MEM). Cells (5-10 x 107 cells/ml) were incubated with lz~I-110-kD 
fragment (2 x los #Ci/ml), in a total volume of 150 #1 of binding buffer, 
for 1 h at room temperature with constant shaking. Specific binding was 
determined by competing with unlabeled 110-kD fragment. After binding, 
the cells were centrifuged for 25 s at 14,000 g and were washed twice with 
500 #1 ice-cold binding buffer. The amount of I~I-ll0-kD protein remain- 
ing in the cell pellet was measured. The binding data were analyzed by using 
the Ligand program (National Institutes of Health, Bethesda, MD) for the 
Macintosh computer. 
Cell Motility Assay 
Cell motility in the presence of fibronectin was measured using a modified 
Boyden chamber (NeuroProbe, Cabin John, MD) as previously described 
(Albini et al., 1987) with slight modifications. The undersurface of 10-~m- 
pore polycarbonate membrane filter (Foretics, Livermore, CA) was first 
precoated with 10 t~g/ml of fibronectin. Lower chambers were filled with 
a-MEM containing 0.1% BSA and 10 t~g/mi of fibronectin. Cells (1 × l0 s) 
were added to the upper chambers in the same media described above except 
without fibronectin. The cells were incubated at 370C for 3, 6, 12, and 24 h 
and then the membranes were fixed in methanol and cells were stained with 
0.5% toluidine blue in 3.7% formaldehyde. The cells on the upper surface 
of the membrane were removed, the membranes were mounted on glass 
slides and the number of ceils that had migrated to the lower surface were 
counted. Four high-magnification microscopic fields were counted per well 
and all experiments were performed in quadruplicate. Migration results are 
expressed in terms of the average number of cells/high-magnification micro- 
scopic field (HMMC) I. 
Matrix Assembly Assay 
Matrix assembly assays were carded out by using 12SI-labeled fibronectin 
as described previously (McKeown-Longo and Mosher, 1985; Morla and 
Ruoslahti, 1992). 
Immunofluorescence 
For fibronectin matrix staining, ceils were grown to confluence on cover- 
slips, washed, and fixed in 3.7% parafonnaldehyde, 10 mM sucrose in PBS 
(pH 7.4) for 30 rain. Cells were then stained with rabbit anti-mouse 
fibronectin antiserum for 2 h followed by rhodamine-labeled goat anti- 
rabbit IgG secondary antibody (Cappel, West Chester, PA). For integrin 
staining, cells were fixed for 10 min, permeabilized with 0.5% NP-40 in 
PBS for 15 min, and then stained with either anti-vinculin, anti-oo/, anti-a5, 
or anti-~ cytoplasmic domain antisera followed by rhodamine-labeled sec- 
ondary antibodies. After antibody treatments, coverslips were mounted 
onto slides with 200 mM n-propyl gallate, 50% glycerol in PBS. 
Results 
Expression of av in CHO Cells 
To test the role of the a~cfll integrin in fibronectin matrix as- 
1. Abbreviation used in this paper: HMMC, high-magnification micro- 
scopic field. 
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Figure 1. Integrin expression in CHO-B2 cells and their transfec- 
tants. (A) Cells were surface labeled with 125I and cell lysates were 
immunoprecipitated either with a mAb to the a5 subunit (P1D6; 
lanes 2, 5, 8, H, and 14), a mAb to the otv subunit (147; lanes 3, 
6, 9, 12, and 15), or a control mAb to ganglioside GM3 (lanes 1, 
4, 7, 10, and 13). The immunoprecipitated proteins were analyzed 
by SDS-PAGE under non-reducing conditions. The following cell 
lines were analyzed; the parental B2 cell line (lanes 1-3); a parental 
vector transfected control cell line, B2/cl (lanes 4-6); an tx5- 
transfected cell line, B2/ot27 (lanes 7-9); and two txv-transfected 
cell lines, B2/v7 (lanes 10--12) and B2/v12 (lanes 13-15). (B) 
Surface-labeled cell lysates were immunoprecipitated with anti-ix5 
cytoplasmic domain antiserum (lanes 2, 6, 10, 14, and 18), anti-txv 
cytoplasmic domain antiserum (lanes 3, 7, 11, 15, and 19), anti- 
B3 cytoplasmic domain antiserum (lanes 4, 8, 12, 16, and 20) or 
a control antiserum prepared against an unrelated antigen (lanes 1, 
5, 9, 13, and 17). The immunoprecipitated proteins were analyzed 
by SDS-PAGE under non-reducing conditions. The cell lines exam- 
ined were B2 (lanes 1-4), B2/cl (lanes 5-8), B2hx27 (lanes 9-12), 
B2/v7 (lanes 13-16), and B2/v12 (lanes 17-20). At the exposure 
level shown here, the human ix5 subunit (lane 8 of A and lane 10 
of B) is not readily discernible. 
sembly and cell motility on fibronectin, a full-length cDNA 
of human av was introduced into an ot5B 1-deficient CHO cell 
line (B2; Schreiner et al., 1989). G418-resistant clones were 
picked and screened for ~v expression by immunoblotting. 
Two clones that expressed high levels of human otv (B2/v7 
and B2/v12) were chosen for further study. The human txv 
associated with the endogenous B1 to form the txvB1 integrin 
in these ceils (Fig. 1 A, lanes 12 and 15). No otv/$1 was de- 
tected in the parental B2 cell line, or in the B2/tx2 7 cell line 
which was transfected with human or5 (Fig. 1 B, lanes 3, 7, 
and 1/), even though the I32 cell line (and the transfectants 
derived from this cell line) expresses an endogenous we 
subunit. The endogenous o~v is associated with a/3 subunit 
that is likely to be/~5, since it was the size of/5 3 or/55, and 
it was not immunoprecipitated by antibodies to/33 (Fig. 1 B, 
lanes 4 and 8). Also, we have found that B2 cells express/$5 
mRNA but no detectable/53 mRNA (not shown). It seems 
that txv becomes associated with /31 in these cells only 
when the av concentration exceeds that of/55 as is the case 
with the otv transfectants. 
Immunoprecipitation with anti-/51 antibodies failed to re- 
veal any/31-containing integrins in B2 cells. However, anti- 
B1 immunoprecipitated ot5~l from B2/ct27 and c~v/51 from 
B2/v7 and B2/v12 cells (data not shown). These results 
confirmed that the human otv associated with the hamster/51 
in the uv transfectants. 
To provide an estimate of the relative amount of ct5/31 and 
o~v~l expressed in the ix5- and otv-transfected cell lines, 
B2/cl, B2/v7, B2/v12, and B2/ct27 cells were subjected to 
FACS analysis with mAb 147 (anti-human txv) and mAb 
P1D6 (anti-human ct5). The results showed that the apparent 
level of ctv/$1 expressed in B2/v12 and B2/v7 cells was ap- 
proximately twofold higher than the level of ct5/31 expressed 
in B2/a27 cells (results obtained with B2/v7 and B2/ot27 are 
shown in Fig. 2). 
av/51 Is a ~bronec t in  Receptor in C H O  Cells 
The av~l integrin has been reported to be a fibronectin 
receptor (Vogel et al., 1990), a vitronectin receptor (Bodary 
and McLean, 1990), and a receptor for type I collagen (Ded- 
har and Gray, 1990). 
The B2/v7 and B2/v12 cells attached to and spread on 
fibronectin, while the parental B2 cells did not. Figs. 3 and 
4 A show the results with the B2/v7 cells. In contrast, the 
parental B2 cells attached to and spread on vitronectin better 
than the av-transfected cells (Figs. 3 and 4 B). These results 
indicate that fibronectin rather than vitronectin is the ligand 
of txv/31 in these CHO cells. 
The attachment of the B2/v7 cells to fibronectin was com- 
pletely inhibited by both anti-otv/$3 and anti-ot5~l polyclonal 
antisera, while a preimmune serum had no effect (Fig. 5 A). 
The anti-o~v/33 antiserum did not inhibit the attachment of the 
B2/ot27 (ot5/51 positive) cells to fibronectin (Fig. 5 B), 
thereby demonstrating the specificity of the inhibition of the 
B2/v7 cells. GRGDSP peptide at 1 mg/ml also fully inhibited 
the attachment of otv-transfected cells to fibronectin, while 
the same concentration of GRGESP peptide had no effect 
(Fig. 5 A). These results indicate that the txv-transfected cells 
attached to fibronectin by using the otvB1 integrin and that 
the RGD sequence is the binding site on fibronectin for otv/51. 
cxv/51 Cannot  Replace cx5/51 in Fibronectin 
Matr ix  Assembly  
We next examined whether otvB1 could replace ot5B1 in 
fibronectin matrix assembly. Cell monolayers were in- 
cubated with ~5I-labeled fibronectin for 1 h (binding of 
fibronectin to cell monolayers) or 24 h (matrix deposition), 
and the amount of radiolabeled fibronectin that was bound 
to the cell monolayer or incorporated into a detergent insolu- 
ble matrix was measured (McKex~n-Longo and Mosher, 
1985). The B2/ot27 cells were the most efficient at both bind- 
ing fibronectin from the medium (Fig. 6 A), and at depositing 
fibronectin into the matrix (Fig 6 B). These cells bound 
Zhang et al. ccv~l in Matrix Assembly and Cell Migration 237 
Z 
2 ~ Q  
2 0 0  
A 
I l l l l n [  ! ~ l ~ n l  1 ~ I l l . n |  ; ; l ~ t l l l  
I B  ! Ila 2 I f l  3 1~ 
C 
. . . . . . .  1,1' . . . . . . . .  . . . . . .  . . . . . . . .  , , , '  
_ _ J  
3~lct  
, ! 'I , H , , w  I , 
1 ~  1 1 o  2 I1~ ] 
B 
i I i 1 ¢ !  
11 
D 
~ *~1 I , i , i , ~  i , , i ,  
l la  I l f l  2 let  ] 
Fluorescence Intensity 
Figure 2. FACS histogram of 
c~v and c~5 integrin expression 
levels. B2/cl (,4 and B), 
B2/v7 (C) and B2/a27 (D) 
cells were subject to FACS 
analysis as described in 
Materials and Methods. Cells 
were stained with either anti- 
c~v (mAb 147, left) or anti-~t5 
(mAb P1D6, r/ght) mAbs. 
and deposited into the matrix approximately 10-fold more 
fibronectin than the parental B2 cells, and approximately 
fivefold more than the txv transfectants, the B2/v7 and 
B2/v12 (Fig. 6 B). 
Immunofluorescence with anti-fibronectin antibodies (Fig. 
7) showed fibronectin fibrils only on B2/a27 cells. To ex- 
clude the possibility that the ditferences in matrix assembly 
would be due to differences in fibronectin expression in 
B2/v7 and B2/ot27 cells, the amount of fibronectin synthesis 
was measured by labeling cells with [35S]methionlne and 
immunoprecipitating medium and cell layer samples with 
an anti-fibronectin antiserum. Both cell lines synthesized 
equivalent amounts of fibmnectin, however, proportionately 
more of the fibronectin was found associated with the cell 
layer in B2/ot27 cells than in B2/v7 cells (results not shown). 
Thus the immunofluorescenee with anti-fibmnectin antibod- 
Figure 3. Attachment and 
spreading of transfected cells 
on fibmnectin and vitronec- 
tin. B2/cl, B2/v7, or B2/cx27 
cells were incubated on 
fibronectin (top) or vitronec- 
tin (bottom) coated plates for 
40 rain at 37°C. Hates were 
then washed, and cells were 
fixed, stained, and then pho- 
tographed. 
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Figure 4. Quantitation of cell attachment. B2/cl ( I ) ,  B2/v7 (e), 
and B2/a27 (&) cells were seeded onto plates coated with various 
concentrations of either fibronectin (,4) or vitronectin (B). After al- 
lowing cells to attach for 25 min at 37°C, the extent of cell adhesion 
was quantitated as described in Materials and Methods. All data 
points are the average of duplicate samples, variations between 
duplicates were typically <6%. 
ies confirmed the results obtained with ~25I-labeled fibro- 
nectin; B2/oe27 cells deposit a fibronectin matrix but the 
oc¢/~l-expressing cells do not. 
~v# l-expressing CHO-B2 Cells Migrate Poorly 
on Fibronectin 
Previous studies have shown that the rate of cell migration 
on fibronectin is correlated to the level of c~5~1 fibronectin 
receptor on the cells (Bauer et al., 1992). As shown in Fig. 
8, B2/c~27 cells migrated significantly better than B2/cl cells 
did on fibronectin. B2/v7 and B2/v12 cells also migrated bet- 
ter than B2/cl cells, however their rate of migration was six- 
to ninefold lower than that of B2/c~27 cells. Thus, while c~5~1 
and c~v~l both function as fibronectin receptors, o~5~1 sup- 
ports cell migration on fibronectin to a greater extent than 
does cw#l. 
B2/cl, B2/v7, B2/v12, and B2/c~27 did not migrate well on 
collagen type I, collagen type IV, or laminin. Moreover, otv 
expression in B2 cells did not restore vitronectin migration, 
as does o~5 expression (Bauer et al., 1992). Since we have 
not found a non-fibronectin matrix protein to which the cells 
adhere well, we are not able to determine the migratory abil- 
ity of the otv-transfected cells on other substrates. 
Binding Affinities of cxv~ l and 0t5131 
To explore possible reasons for the lack of matrix deposition 
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Figure 5. Inhibition of cell attachment with peptides and anti- 
integrin antibodies. The B2/v7 (A) or B2/c~27 ceils (B) were seeded 
onto fibmncctin coated plates in ¢z-MEM in the absence (C) or in 
the presence of 1 mg/ml GRGDSP (RGD), 1 mg/ml GRGESP 
(RGE), 1:10 dilution of anti-a5/31 antiserum (anti-cxS/31), 1:10 dilu- 
tion of anti-c~v/~3 antiserum (anti-ow/~3), or 1:10 dilution of preim- 
mune serum (PI), and cell attachment was quantitated as described 
in Materials and Methods. 
the affinities of otv#l and ot5/~l for fibronectin by measuring 
the binding of a l~5I-labeled ll0-kD cell-binding fibronectin 
fragment to the B2/v7 and B2/ot27 cells in suspension. The 
half-maximal binding of the '2q-ll0-kD fragment to B2/v7 
and B2/o~27 cells was reached at 20 min, with maximal bind- 
ing at 60 min (data not shown), which agrees with previous 
results (Akiyama and Yarnada, 1985). Analysis of the bind- 
ing of the ~2q-ll0-kD fragment to B2/v7 cells indicated one 
class of binding sites with a dissociation constant of 2.4 + 
1.4 x 10 -7 M (Fig. 9 A), and with 3.5 + 2.4 x 104 binding 
sites per cell. The binding results obtained with B2/ot27 cells 
were also consistent with one class of binding sites, with a 
dissociation constant of 5.7 + 1.7 x 10- 8 M, and 1.8 + 0.5 
x 104 binding sites per cell (Fig. 9 B). The results indicate 
that o~v/~l has a fourfold lower affinity for the ll0-kD frag- 
ment than ~5/31, however, the B2/v7 cells had approximately 
twofold more available binding sites than the B2/ot27 cells 
for the ll0-kD fragment. 
c~vB l and ~5131 have Different 
SubceUular Localizations 
Immunofluorescence showed that in B2/o~27 cells seeded 
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Figure 6. Fibronectin binding and fibronectin matrix assembly by 
txv and ix5 transfectants. Confluent monolayers of B2/cl, B2/v7, 
B2/v12, and B2/ct27 cells were incubated with 12SI-labeled 
fibronectin for either 1 h (A), or 24 h (B). The total mount of 
I~I-labeled fibronectin bound to cells (A), or the amount of 125I- 
labeled fibronectin associated with a deoxycholate insoluble matrix 
(B) was determined as described in Materials and Methods. 
Figure 7. Immunofiuorescenee detection of fibroneetin matrix 
deposition by ~xv and ix5 transfectants. B2/v7 and B2/ct27 cells 
were grown on coverslips, and then processed for indirect immune- 
fluorescence with anti-fibronectin antiserum (top), or omitting first 
antibody (bottom), followed by rhodamine-labeled second anti- 
body. Bar, 5 #m. 
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Figure 8. Motility of integrin subunit transfectants on fibronectin. 
Cell motility assays were performed at 37"C for 3, 6, 12, and 24 h 
as described in Materials and Methods. The results at each time 
point are the mean cell number of 32 randomly selected high 
magnification microscopic fields. (B, B2/cl cells; e, B2/v7 cells; 
&, B2/v12 cells; and n, B2/tx27 cells.) 
onto fibronectin, the or5, txv, and/51 integrin subunits were 
localized to structures identical to focal contacts, as visual- 
ized with antibodies to vinculin (Fig. 10, right). In B2/v7 
cells (Fig. 10, left) and B2/v12 cells (not shown), the otv and 
/51 subunits were predominantly diffusely localized and not 
found in focal contacts, although some otv and B1 staining 
can occasionally be found in focal contact-like structures. 
No specific staining was detectable with anti-or5 antibodies 
on B2/v7 or B2/v12 cells, due to the very low level of or5 
in these cells. Thus, while ot5/51 localized to focal contacts 
in B2/tx27 cells, otv/51 was diffusely localized in B2/v7 and 
B2/v12 cells, indicating that these two integrins occupy 
different subcellular localization in B2 cells. 
Discussion 
We have found that transfecting the human o~v integrin 
subunit into CHO cells which are deficient in the or5 subunit 
results in the expression of a human av  hamster/51 integrin, 
and that this integrin functions as a fibronectin receptor and 
not a vitronectin receptor in these cells. Moreover, although 
,v/51 and a5/51 are both fibronectin receptors and bind to the 
RGD site, c~,/51 could not substitute for ot5/51 in fibronectin 
matrix assembly or in cell migration on fibronectin. 
In agreement with earlier results from our laboratory 
(Vogel et al., 1990), the present study indicates that the av/51 
integrin is a fibronectin receptor. For example, the ,v/51 ex- 
pressing cells (B2/v7) attached to and spread on a fibronec- 
tin substratum whereas the parental B2 cells did not. In addi- 
tion, the attachment of B2/v7 cells to fibronectin was 
inhibited by both an anti-otv/53 antiserum and an anti-ix5/51 
antiserum, which is in agreement with the conclusion that 
otv/51 mediated the attachment. Also, B2/v7 cell binding to 
fibronectin was inhibited by RGD, which has been shown to 
be the binding site for txvBl (Bodary and McLean, 1990; 
Vogel et al., 1990). Our results do not support the previously 
reported designation of txvB1 as a vitronectin receptor (]30- 
dary and McLean, 1990); the attachment of the ow/51 ex- 
pressing B2/v7 and B2/v12 cells to vitronectin was actually 
lower than that of their parental counterpart. However, since 
the integrin specificities of fibronecfin and vitronectin are 
very similar (Pytela et al., 1985b), it is possible that 
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Figure 9. Displacement carves and Scatchard plots for the binding 
of lz~I-110-kD fibronectin fragment to B2/v7 and B2/ot27 ceils. 
B2/v7 ceils (,4) and B2/ot27 cells (B) were incubated with t2~I-ll0- 
kD fragment plus various concentrations of unlabeled 110-kD frag- 
ment for 1 h. The amount of labeled ll0-kD fragment bound to the 
ceils was quantitated, and the displacement curves and Scatchard 
plots (insets) were generated as described in Materials and 
Methods. 
vitroneetin binding by ow/31 may occur in other cells and 
other experimental conditions. We conclude that otvB1 is a 
fibroneetin receptor when expressed in ot5-defieient CHO 
cells. 
A previous study suggested that some/51 integrin other 
than ot5/~l may also be involved in fibronectin matrix forma- 
tion (Fogerty et al., 1990). Our results show that although 
ow#l is a fibronectin receptor that binds to the RGD cell at- 
tachment site on fibronectin, t~v/~l cannot substitute for 
~5#1 during fibronectin matrix assembly. Another property 
in which the ot5#l- and av#l-expressing cells differ is in 
their ability to migrate on fibronectin. Our results, and previ- 
ous work (Bauer et al., 1992), indicate that the ot5/31 integrin 
allows CHO cells to migrate on fibronectin. We found, how- 
ever, that the otv#l integrin supported migration to a much 
lesser extent. Thus, the cells expressing c~v/31 are deficient 
both in the ability to assemble a fibronectin matrix and in 
their ability to migrate on fibronectin, when compared to the 
or5# 1-expressing cells. 
One possible reason for the differences in matrix assembly 
and migratory ability of the cells expressing ot5/31 and ow/~l 
is that tzv/31 has a lower affinity for fibronectin than does 
ot5/~l. It is possible that while the affinity of o~v/31 is sufficient 
Figure 10. Immunofluorescence detection of integdns and vinculin 
in av and c~5 transfectants. B2/v7 (left) and B2/c~27 (right) cells 
were seeded onto fibronectin-coated coverslips for 3 h at 37°C. 
Cells were processed for indirect immunofluorescence with either 
anti-vinculin antibodies, anti-otv cytoplasmic domain antibodies, 
anti-or5 cytoplasmic domain antibodies, or anti-#l cytoplasmic do- 
main antibodies as indicated in the figure. Bar, 5 #m. 
to allow for cell attachment and spreading on fibronectin, it 
is too low to support either matrix assembly or cell migra- 
tion on fibronectin. 
Another reason for the inability of ow#l to support matrix 
assembly and cell migration, that is not mutually exclusive 
with the low affinity, may be that ctv#l does not localize to 
focal contacts in cells that are attached to fibronectin. Previ- 
ous studies have suggested that integrins interact with the 
cytoskeleton at focal contacts (Chen et al., 1985). The ot5/31 
and otv/~3 integrins have been implicated in interactions with 
the actin cytoskeleton, since these integrins localize to focal 
contacts when fibroblasts spread on either an RGD peptide, 
vitronectin or fibronectin (Singer et al., 1988). In our study, 
when cells were seeded on fibronectin, an otv-containing 
integrin (most likely av#5, results not shown) localized to 
focal contacts only when ot5/31 was present in the cell. Little 
otv- or/~l-contalning integrin staining was found in focal con- 
tacts in the ow-transfected cells, even though these cells had 
focal contacts. Since interaction with cytoskeletal proteins 
may determine whether an integrin localizes to focal con- 
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tacts, it is possible that otv/31 does not interact with cytoskel- 
etal proteins in the same manner as o~5/51. The tx, v and or5 
transfectants may be useful tools for exploring questions 
other than matrix assembly, such as the interactions of inte- 
grins with cytoskeletal and focal contact proteins. 
Finally, it may be that the tx5/51 integrin has some second- 
ary effect on the fibronectin molecule beyond the binding of 
the RGD sequence, and that this effect is needed for matrix 
assembly and migration. A possible candidate for a mediator 
of such an effect is a secondary binding site discovered re- 
cently in integrins (Vogel et al., 1993). This binding site is 
directed toward sequences that are rich in basic amino acids 
and has a distinct specificity in different integrins. 
In summary, our results demonstrate that av/31 can func- 
tion as a fibronectin receptor but is not able to support either 
fibronectin matrix assembly or cell migration on fibronectin 
in CHO cells. This reveals an unexpected difference in the 
functions of two fibronectin binding integrins in fibronectin 
matrix assembly and cell migration on fibronectin. Studying 
this specificity should help us to understand the process of 
matrix assembly and cell motility in greater detail. 
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